Highlights from the SWG
On November 24, 2022, the SWG on Red Cells and Iron held its annual Business meeting virtually which was chaired by Prof. Ali Taher and Prof. Achille Iolascon. This was a good opportunity for all SWG members to meet together and discuss important developments in the field. The meeting program was divided into presenting the ongoing work on developing guidelines/recommendations on specific topics and discussing the Pros and Cons of Different Treatment Modalities in Hemoglobinopathies.
During the first part of the activity, M. De Montalembert (France)/L. De Franceschi (Italy) presented their progress in developing the guidelines on gene therapy/editing in SCD and A. Iolascon displayed the current status of the guidelines on the Diagnosis and Management of ID/IDA. At the end of this session, A. Taher outlined the list of topics for Future Guideline-development by the SWG on Red Cells and Iron.
The second part of the activity was reserved for the Pros and Cons of Different Treatment Modalities in Hemoglobinopathies. Thus, J. de la Fuente (UK) thoroughly described the role of Bone Marrow Transplantation and MD. Cappellini (Italy) presented the different Novel Pharmacological Agents under development. The meeting finished with a fruitful discussion and the Chairs closed the meeting by outlining the list of topics for future activities and webinars by the SWG on Red Cells and Iron for the year 2023.